U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 68

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr2:20205993
GRCh38:
Chr2:20006232
MATN3K101RMultiple epiphyseal dysplasia type 5Uncertain significance
(Apr 3, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr2:20205927
GRCh38:
Chr2:20006166
MATN3A123VMultiple epiphyseal dysplasia type 5Likely pathogenic
(Apr 1, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr2:20206011
GRCh38:
Chr2:20006250
MATN3R95QMultiple epiphyseal dysplasia type 5Uncertain significance
(Nov 9, 2021)
criteria provided, single submitter
4.
GRCh38:
Chr2:19998776-20009244
MATN3, WDR35-DTMultiple epiphyseal dysplasia type 5Pathogenic
(Oct 7, 2021)
no assertion criteria provided
5.
GRCh37:
Chr2:20205818
GRCh38:
Chr2:20006057
MATN3Multiple epiphyseal dysplasia type 5Uncertain significancecriteria provided, single submitter
6.
GRCh37:
Chr2:20212243
GRCh38:
Chr2:20012482
MATN3Multiple epiphyseal dysplasia type 5Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
7.
GRCh37:
Chr2:20212233
GRCh38:
Chr2:20012472
MATN3P54Tnot provided, Multiple epiphyseal dysplasia type 5Uncertain significance
(Jan 11, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr2:20212213
GRCh38:
Chr2:20012452
MATN3Multiple epiphyseal dysplasia type 5Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
9.
GRCh37:
Chr2:20212208
GRCh38:
Chr2:20012447
MATN3A62Vnot provided, Multiple epiphyseal dysplasia type 5Uncertain significance
(Nov 1, 2021)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr2:20212196
GRCh38:
Chr2:20012435
MATN3S66TMultiple epiphyseal dysplasia type 5Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
11.
GRCh37:
Chr2:20205562
GRCh38:
Chr2:20005801
MATN3V245Mnot provided, Multiple epiphyseal dysplasia type 5Conflicting interpretations of pathogenicity
(Sep 7, 2022)
criteria provided, conflicting interpretations
12.
GRCh37:
Chr2:20205533
GRCh38:
Chr2:20005772
MATN3Multiple epiphyseal dysplasia type 5Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr2:20192935
GRCh38:
Chr2:19993174
MATN3, WDR35-DTMultiple epiphyseal dysplasia type 5Uncertain significance
(Mar 30, 2018)
criteria provided, single submitter
14.
GRCh37:
Chr2:20192798
GRCh38:
Chr2:19993037
MATN3, WDR35-DTMultiple epiphyseal dysplasia type 5Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
15.
GRCh37:
Chr2:20192720
GRCh38:
Chr2:19992959
MATN3, WDR35-DTMultiple epiphyseal dysplasia type 5Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
16.
GRCh37:
Chr2:20192661
GRCh38:
Chr2:19992900
MATN3, WDR35-DTMultiple epiphyseal dysplasia type 5Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
17.
GRCh37:
Chr2:20206020
GRCh38:
Chr2:20006259
MATN3R92HMultiple epiphyseal dysplasia type 5Likely benign
(Jan 13, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr2:20192560
GRCh38:
Chr2:19992799
MATN3, WDR35-DTMultiple epiphyseal dysplasia type 5Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
19.
GRCh37:
Chr2:20192123
GRCh38:
Chr2:19992362
MATN3, WDR35-DTMultiple epiphyseal dysplasia type 5Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
20.
GRCh37:
Chr2:20192113
GRCh38:
Chr2:19992352
MATN3, WDR35-DTMultiple epiphyseal dysplasia type 5Benign
(Jan 12, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr2:20191917
GRCh38:
Chr2:19992156
MATN3, WDR35-DTMultiple epiphyseal dysplasia type 5Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
22.
GRCh37:
Chr2:20191883
GRCh38:
Chr2:19992122
MATN3, WDR35-DTMultiple epiphyseal dysplasia type 5Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
23.
GRCh37:
Chr2:20191876
GRCh38:
Chr2:19992115
MATN3, WDR35-DTMultiple epiphyseal dysplasia type 5Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
24.
GRCh37:
Chr2:20191828
GRCh38:
Chr2:19992067
MATN3, WDR35-DTMultiple epiphyseal dysplasia type 5Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
25.
GRCh37:
Chr2:20205991
GRCh38:
Chr2:20006230
MATN3V102Lnot provided, Multiple epiphyseal dysplasia type 5Uncertain significance
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr2:20205818
GRCh38:
Chr2:20006057
MATN3Multiple epiphyseal dysplasia type 5Uncertain significance
(Jun 11, 2017)
criteria provided, single submitter
27.
GRCh37:
Chr2:20205781
GRCh38:
Chr2:20006020
MATN3E172KMultiple epiphyseal dysplasia type 5Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
28.
GRCh37:
Chr2:20203016
GRCh38:
Chr2:20003255
MATN3, WDR35-DTMultiple epiphyseal dysplasia type 5Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
29.
GRCh37:
Chr2:20202932
GRCh38:
Chr2:20003171
MATN3, WDR35-DTMultiple epiphyseal dysplasia type 5Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
30.
GRCh37:
Chr2:20205772
GRCh38:
Chr2:20006011
MATN3T175Pnot provided, Inborn genetic diseases, Multiple epiphyseal dysplasia type 5
Uncertain significance
(Dec 16, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr2:20205771
GRCh38:
Chr2:20006010
MATN3T175KMultiple epiphyseal dysplasia type 5Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
32.
GRCh37:
Chr2:20200305
GRCh38:
Chr2:20000544
MATN3, WDR35-DTnot provided, Multiple epiphyseal dysplasia type 5Conflicting interpretations of pathogenicity
(Apr 29, 2021)
criteria provided, conflicting interpretations
33.
GRCh37:
Chr2:20200285
GRCh38:
Chr2:20000524
MATN3, WDR35-DTI362TMultiple epiphyseal dysplasia type 5Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
34.
GRCh37:
Chr2:20200256
GRCh38:
Chr2:20000495
MATN3, WDR35-DTH372NMultiple epiphyseal dysplasia type 5Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
35.
GRCh37:
Chr2:20205636
GRCh38:
Chr2:20005875
MATN3V220AMultiple epiphyseal dysplasia type 5Uncertain significance
(May 28, 2019)
criteria provided, single submitter
36.
GRCh37:
Chr2:20212303
GRCh38:
Chr2:20012542
MATN3not provided, Multiple epiphyseal dysplasia type 5Conflicting interpretations of pathogenicity
(Sep 28, 2022)
criteria provided, conflicting interpretations
37.
GRCh37:
Chr2:20212162
GRCh38:
Chr2:20012401
MATN3not provided, Multiple epiphyseal dysplasia type 5Conflicting interpretations of pathogenicity
(Mar 26, 2022)
criteria provided, conflicting interpretations
38.
GRCh37:
Chr2:20201813
GRCh38:
Chr2:20002052
MATN3, WDR35-DTConnective tissue disorder, not provided, Multiple epiphyseal dysplasia type 5
Likely benign
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr2:20205754
GRCh38:
Chr2:20005993
MATN3R181*Multiple epiphyseal dysplasia type 5Uncertain significance
(Oct 31, 2018)
criteria provided, single submitter
40.
GRCh37:
Chr2:20205769
GRCh38:
Chr2:20006008
MATN3V176LConnective tissue disorder, not provided, Spondyloepimetaphyseal dysplasia, matrilin-3 type,
Multiple epiphyseal dysplasia type 5
Uncertain significance
(Oct 29, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr2:20199298-20199299
GRCh38:
Chr2:19999537-19999538
WDR35-DT, MATN3Multiple epiphyseal dysplasia type 5Likely pathogenic
(Jul 3, 2018)
criteria provided, single submitter
42.
GRCh37:
Chr2:20203006
GRCh38:
Chr2:20003245
MATN3, WDR35-DTV278Inot provided, Multiple epiphyseal dysplasia type 5Uncertain significance
(Sep 25, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr2:20206016
GRCh38:
Chr2:20006255
MATN3not provided, Multiple epiphyseal dysplasia type 5Likely benign
(Aug 29, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr2:20205965
GRCh38:
Chr2:20006204
MATN3not provided, Multiple epiphyseal dysplasia type 5, Connective tissue disorder
Conflicting interpretations of pathogenicity
(Sep 29, 2022)
criteria provided, conflicting interpretations
45.
GRCh37:
Chr2:20205946
GRCh38:
Chr2:20006185
MATN3P117SMultiple epiphyseal dysplasia type 5, not providedLikely benign
(Jul 30, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr2:20205941
GRCh38:
Chr2:20006180
MATN3Multiple epiphyseal dysplasia type 5, Connective tissue disorder, not provided
Benign/Likely benign
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr2:20205631
GRCh38:
Chr2:20005870
MATN3V222Mnot specified, Multiple epiphyseal dysplasia type 5Conflicting interpretations of pathogenicity
(Jan 1, 2019)
criteria provided, conflicting interpretations
48.
GRCh37:
Chr2:20205624
GRCh38:
Chr2:20005863
MATN3R224Qnot provided, Multiple epiphyseal dysplasia type 5, Connective tissue disorder
Uncertain significance
(Sep 7, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr2:20192828
GRCh38:
Chr2:19993067
MATN3, WDR35-DTMultiple epiphyseal dysplasia type 5Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr2:20192696
GRCh38:
Chr2:19992935
MATN3, WDR35, WDR35-DTMultiple Epiphyseal Dysplasia, Dominant, not provided, Multiple epiphyseal dysplasia type 5,
Short rib-polydactyly syndrome, Cranioectodermal dysplasia
Benign
(Nov 12, 2018)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr2:20192212
GRCh38:
Chr2:19992451
MATN3, WDR35-DTMultiple epiphyseal dysplasia type 5Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
52.
GRCh37:
Chr2:20212206
GRCh38:
Chr2:20012445
MATN3S63AConnective tissue disorder, not provided, not specified,
Multiple epiphyseal dysplasia type 5
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr2:20197018
GRCh38:
Chr2:19997257
MATN3, WDR35-DTR391Cnot provided, Multiple epiphyseal dysplasia type 5, not specified
Benign/Likely benign
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr2:20212331
GRCh38:
Chr2:20012570
MATN3L21RInborn genetic diseases, not specified, not provided,
Multiple epiphyseal dysplasia type 5
Conflicting interpretations of pathogenicity
(Sep 27, 2022)
criteria provided, conflicting interpretations
55.
GRCh37:
Chr2:20202929
GRCh38:
Chr2:20003168
MATN3, WDR35-DTnot specified, Multiple epiphyseal dysplasia type 5, not provided
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr2:20205541
GRCh38:
Chr2:20005780
MATN3E252Knot specified, Multiple epiphyseal dysplasia type 5, Connective tissue disorder,
not provided
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr2:20192931
GRCh38:
Chr2:19993170
MATN3, WDR35, WDR35-DTShort rib-polydactyly syndrome, not specified, Cranioectodermal dysplasia,
Multiple Epiphyseal Dysplasia, Dominant, not provided, Multiple epiphyseal dysplasia type 5
Benign/Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr2:20197030
GRCh38:
Chr2:19997269
WDR35-DT, MATN3Connective tissue disorder, not specified, not provided,
Multiple epiphyseal dysplasia type 5
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr2:20203046
GRCh38:
Chr2:20003285
MATN3, WDR35-DTnot provided, Multiple epiphyseal dysplasia type 5Conflicting interpretations of pathogenicity
(Mar 2, 2022)
criteria provided, conflicting interpretations
60.
GRCh37:
Chr2:20205680
GRCh38:
Chr2:20005919
MATN3not specified, not provided, Multiple epiphyseal dysplasia type 5
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr2:20205848
GRCh38:
Chr2:20006087
MATN3not specified, not provided, Multiple epiphyseal dysplasia type 5
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr2:20205936
GRCh38:
Chr2:20006175
MATN3T120MMultiple epiphyseal dysplasia type 5, Spondyloepimetaphyseal dysplasia, matrilin-3 type, not provided
Pathogenic/Likely pathogenic
(Aug 13, 2021)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr2:20205913
GRCh38:
Chr2:20006152
MATN3A128PMultiple epiphyseal dysplasia type 5Pathogenic
(Aug 1, 2003)
no assertion criteria provided
64.
GRCh37:
Chr2:20212184
GRCh38:
Chr2:20012423
MATN3R70Hnot provided, Multiple epiphyseal dysplasia type 5Uncertain significance
(Sep 2, 2021)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr2:20205639
GRCh38:
Chr2:20005878
MATN3A219DMultiple epiphyseal dysplasia type 5Pathogenic
(Jan 1, 2004)
no assertion criteria provided
66.
GRCh37:
Chr2:20202930
GRCh38:
Chr2:20003169
MATN3, WDR35-DTT303MConnective tissue disorder, not specified, not provided,
Multiple epiphyseal dysplasia type 5
Benign
(Oct 23, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr2:20205934
GRCh38:
Chr2:20006173
MATN3R121Wnot provided, Multiple epiphyseal dysplasia type 5Pathogenic/Likely pathogenic
(Aug 19, 2022)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr2:20205714
GRCh38:
Chr2:20005953
MATN3V194DMultiple epiphyseal dysplasia type 5Pathogenic
(Aug 1, 2001)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination